AlzeCure Pharma (Sweden)
AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders.
Basic Information
- Category: business
- Website: https://www.alzecurepharma.se/en/
Documented Facts
- Inception (Wikidata): 2016 (Source 3: Wikidata Q61932160, revision 2534916143)
- Country (Wikidata; date unspecified): Sweden (Source 3: Wikidata Q61932160, revision 2534916143; Source 4: Wikidata label: Q34, revision 2547805093)
- Official website (Wikidata; date unspecified): https://www.alzecurepharma.se/en/ (Source 3: Wikidata Q61932160, revision 2534916143)
Evidence and Sources
- AlzeCure Pharma (Sweden) — Official Site (official)
- AlzeCure Pharma (Sweden) on linkedin (social)
- Wikidata Q61932160, revision 2534916143 (knowledge-base)
- Wikidata label: Q34, revision 2547805093 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about AlzeCure Pharma (Sweden).
- Canonical profile: https://brandsource.ai/brands/alzecure-pharma-sweden
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/alzecure-pharma-sweden/json-ld
- Citation profile API: https://brandsource.ai/api/brands/alzecure-pharma-sweden/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.